NHSBT is collecting COVID-19 convalescent plasma for a major coronavirus treatment trial, and if the trial is successful, widespread use in hospitals. Convalescent plasma is the antibody-rich plasma of people who have recovered from COVID-19, which can be transfused into people with COVID-19 who are struggling to develop their own immune response.
Collaborative design with NHSBT for COVID-19 Convalescent Plasma Collection
Anyone who has had coronavirus or the symptoms can offer to donate at a donor centre by calling 0300 123 23 23 or completing the online form at www.nhsbt.nhs.uk
Co design and innovation with NHSBT
- Donor chair adapted for the Convalescent Plasma Collection Programme
- Light weight screens designed and supplied for additional privacy
Convalescent plasma is the antibody-rich plasma of people who have recovered can be transfused into people who are struggling to develop their own immune response.
NHSBT is leading the collection programme on behalf of the Government. NHSBT’s Clinical Trial’s Unit is collaborating with the REMAP-CAP and RECOVERY trials. The trials will investigate whether transfusions may improve a patient’s speed of recovery and chances of survival.
Convalescent plasma is being collected at NHSBT’s 23 donor centres around the country. Donation takes about 45 minutes.
Your body usually replaces the plasma you’ve donated in 24-48 hours and you can get on with your normal day after donating. Your body quickly replaces the antibodies and people can donate plasma as often as every two weeks.
Potential donors are being prioritised so there may be a delay in responding to some people. People who became more ill with COVID-19 are more likely to have high antibody levels. For this reason, men, people of middle age and over, and people from black and Asian communities, are priority potential donors.
NHSBT is urgently trying to collect plasma and is creating additional temporary donor centres around the country. However, London’s large population and high number of early infections and recovered patients have made it the number one priority area for donations.
Convalescent plasma is the antibody-rich plasma of people who have recovered from COVID-19, which can be transfused into people who are struggling to develop their own immune response.
- Walljam – ball sports technology business revolution
- Renfrew Group exhibiting at SEHTA’s 2021 International MedTech Expo & Conference
- An opportunity for collaboration with ‘The practical translation of leading research and innovation, directly into cancer care…
- The Technology Transforming Healthcare – Looking beyond Covid, what are the Societal and Economic drivers?
- KBS Korean Broadcasting Service visits Renfrew Group to look at design and innovation in the public sector